Skip to content

Trial · Interventional

Status unknownPhase 4Registry data

Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction

NCTNCT01582542 (opens ClinicalTrials.gov in a new tab)Other id0366-11-RMC
Open at ClinicalTrials.govAsk about this trial

Overview

Status
Status unknown
Phase
Phase 4
Enrollment
50 participants (estimated)
Sponsor
Rabin Medical Center · Other
Design
Allocation not applicable · Open label (no masking)
Countries
1 country

Israel

Start
Apr 2012
Primary completion
Dec 2013 (estimated)
Completion
Mar 2014 (estimated)
First posted
20 Apr 2012 (estimated)
Last update posted
20 Apr 2012 (estimated)
Conditions
Nocturnal Enuresis

Timeline

1 trial

  • Completed
  • Ongoing
  • Not yet recruiting
  • Stopped
  • Estimated dates (est.)
  • Results posted
2012201320142015
  1. Ph 4

    Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction

    NCT01582542

    Apr 2012 to est. Mar 2014

Registry summary

Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.

The purpose of this study is to prospectively assess whether Desmopressin, given for a period of month to patients after radical cystectomy with orthotopic bladder reconstruction, improves and lowers the rate of nocturnal enuresis.

Interventions

  • DesmopressinDrug

Arms1

  • Experimental

    Desmopressin

Primary outcomes1

Outcomes the sponsor listed as primary.

  1. Rate of improvement in Nocturnal incontinence

    Time frame · One month

Posted results

Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.

No results are posted for this trial.

A trial that is still running, or that stopped early, may post results later.

Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works

Studies0

Studies that cite this trial.

No study cites this trial.

Eligibility

Who could join, as posted.

Sex
All
Age
from 18 Years
Healthy volunteers
Not accepted
Inclusion and exclusion criteria, as posted
Inclusion Criteria: * Age above 18 * Able to give informed consent * Patients afte radical cystectomy with orthotopic bladder reconstruction with night time incontinence Exclusion Criteria: * Patients with after radical cystectomy with orthotopic bladder reconstruction with daytime urinary incontinence * Patients already treated with Desmopressin due to other reasons. * Patients with an allergy or insensitivity to Desmopressin. * Patients with known hyponatremia * Patients with severe chronic renal failure and creatinine clearance of below 50 cc/sec. * Patients with severe congestive heart failure * Patients with active urinary tract infection * Patients taking drug therapy which can interact with Desmopressin and affect it's action.Examples include Diuretics, Tricyclic antidepressants, Carbamezapine and Chlorpropamide AND Indomethacin. * Patients with an indwelling urinary catheter.

PepBank is a research reference. Talk to a doctor before you use any peptide.